Branko Milanovic is writing some lovely stuff at the moment:
- Marx in Amerika: musing about whether Marxism is relevant to today’s very different brand of US capitalism
- Can you have a boring life and be a first-rate social scientist? (He doubts it, which could be bad news for the economics profession…)
Every day brings a new headline on the UK’s depressing decay from Global Britain to Little Britain:
- UK cuts grants for small aid charities to save ‘less than cost of No 10 press room’
- UK aid cuts will put tens of thousands of children at risk of famine, says Save the Kids
Top tips on development jobs from a series of LSE student-organized webinars for recent grads,
Vaccines vaccines vaccines. Got a blog coming on that, but in the meantime:
- How David beat Goliath: Advocacy groups seized a moment, and found allies. Shame it’s gated, but check out this killer fact: ‘In 2020, PhRMA, the drug industry lobbying organization, spent over $25 million lobbying Washington. The U.S. Chamber of Commerce, the business lobby and aggressive opponent of relaxing intellectual property restrictions, spent $70 million. Public Citizen, by comparison, reported spending $420,000 on lobbying last year. Oxfam spent $353,000, and MSF spent $0.’ Makes the original David v Goliath seem quite fair, actually…..
- Pfizer forecasts $26bn from annual sales of Covid-19 vaccine
Paying Teachers for Performance: Does It Really Work? Good summary of the evidence on a fraught issue
Fancy a job as Director of Operations? Not when you see the fine print. Yet billions still sign up anyway – why? ht Mwanahamisi Singano